ASELAGE STEVE
SEC CIK 1221599 · EDGAR
BoughtSold
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
ASELAGE STEVE made no open-market trades at BCRX in the last 12 months.
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | A - Grant | $0.00 | +6,820 | 70.2K | +11% | $0 |
| I | 2024-05-29 | 2024-05-24 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | P - Purchase | $6.40 | +2,500 | 2,500 | New | +$16.0K |
| D | 2023-06-15 | 2023-06-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | A - Grant | $0.00 | +16.7K | 63.3K | +36% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | A - Grant | $0.00 | +12.9K | 46.6K | +38% | $0 |
| 2022-06-02 | 2022-05-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | A - Grant | $9.31 | +569 | 33.7K | +2% | +$5,297 | |
| 2022-05-12 | 2022-05-11 | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | S - Sale | $21.92 | -2,575 | 146.9K | -2% | -$56.4K | |
| 2022-03-02 | 2022-02-28 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | A - Grant | $16.61 | +301 | 33.2K | +0.9% | +$5,000 | |
| 2021-12-02 | 2021-11-30 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | A - Grant | $12.06 | +414 | 32.9K | +1% | +$4,993 | |
| 2021-11-18 | 2021-11-16 | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | S - Sale | $29.39 | -31.8K | 149.5K | -18% | -$934.6K | |
| D | 2021-11-09 | 2021-11-05 | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | S - Sale+OE | $26.23 | -10.0K | 161.8K | -6% | -$262.3K |
| D | 2021-11-09 | 2021-11-05 | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | M - OptEx | $16.23 | +10.0K | 171.8K | +6% | +$162.3K |
| MI | 2021-11-03 | 2021-11-01+ | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | S - Sale | $29.69 | -8,500 | 19.5K | -30% | -$252.4K |
| MI | 2021-11-03 | 2021-02-04+ | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | G - Gift | $0.00 | +28.0K | 25.0K | New | $0 |
| M | 2021-11-03 | 2021-02-04+ | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | G - Gift | $0.00 | -28.0K | 164.8K | -15% | $0 |
| DM | 2021-10-08 | 2021-10-07 | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | S - Sale+OE | $26.25 | -60.0K | 189.8K | -24% | -$1.57M |
| D | 2021-10-08 | 2021-10-07 | TVTX | Travere Therapeutics, Inc. | ASELAGE STEVE | Dir | M - OptEx | $16.23 | +60.0K | 249.8K | +32% | +$973.8K |
| 2021-09-02 | 2021-08-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Dir | A - Grant | $15.92 | +314 | 32.4K | +1.0% | +$4,999 |
Purchase Sale Sale after option exercise All abbreviations